Safety signal detection and evaluation in clinical development programs: A case study of tofacitinib

Feb-18

Pharmacoepidemiology

AUTHORS : Gorana Dasic, Pfizer Inc, 235 E 42nd St, New York, NY 10017, USA – Email: Gorana.Dasic@pfizer.com

JOURNAL : Pharmacology Research & Perspectives

REFERENCE: 6(1)

DOI : 10.1002/prp2.371

Read more